Lapatinib or trastuzumab plus taxane therapy for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results of NCIC CTG MA.31

1. Gelmon, K.A.
2. Boyle, F.M.
3. Kaufman, B.
4. Huntsman, D.G.
5. Manikhas, A.
6. Di Leo, A.
7. Martin, M.
8. Schwartzberg, L.S.
9. Lemieux, J.
10. Aparicio, S.
11. Shepherd, L.E.
12. Dent, S.
13. Ellard, S.L.
14. Tonkin, K.
15. Pritchard, K.I.
16. Whelan, T.J.
17. Nomikos, D.
18. Nusch, A.
19. Coleman, R.E.
20. Mukai, H.
21. Tjulandin, S.
22. Khasanov, R.
23. Rizel, S.
24. Connor, A.P.
25. Santillana, S.L.
26. Chapman, J.-A.W.
27. Parulekar, W.R.
28. Show all authors +